Technical Analysis for ICVX - Icosavax, Inc.

Grade Last Price % Change Price Change
D 29.38 1.31% 0.38
ICVX closed up 0.03 percent on Monday, September 27, 2021, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical ICVX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 1.31%
NR7 Range Contraction 1.31%
Inside Day Range Contraction 1.31%
Wide Bands Range Expansion 1.31%
Up 3 Days in a Row Strength 1.31%
Oversold Stochastic Weakness 1.31%
Lower Bollinger Band Walk Weakness 1.35%
Wide Bands Range Expansion 1.35%
Oversold Stochastic Weakness 1.35%
Stochastic Buy Signal Bullish 4.56%
Older End-of-Day Signals for ICVX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% 34 minutes ago
Rose Above Previous Day's High about 3 hours ago
Outside Day about 3 hours ago
60 Minute Opening Range Breakout about 4 hours ago
Up 1% about 4 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-A12, an respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-121, a vaccine candidate with RSV target; IVX-241, a vaccine candidate with hMPV target; IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2^ target indication; and IVX-421, a variant RBD antigen with SARS-CoV-2^ target indication. The company was incorporated in 2017 and is headquartered in Seattle, Washington.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Infectious Diseases Platform Technology Respiratory Diseases

Is ICVX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 49.99
52 Week Low 21.7
Average Volume 246,926
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 35.51
10-Day Moving Average 32.04
Average True Range 3.49
ADX 23.61
+DI 13.96
-DI 28.27
Chandelier Exit (Long, 3 ATRs) 31.36
Chandelier Exit (Short, 3 ATRs) 35.53
Upper Bollinger Bands 45.83
Lower Bollinger Band 25.20
Percent B (%b) 0.18
BandWidth 58.08
MACD Line -1.59
MACD Signal Line -0.16
MACD Histogram -1.4276
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.37
Resistance 3 (R3) 30.35 29.86 30.14
Resistance 2 (R2) 29.86 29.51 29.88 30.07
Resistance 1 (R1) 29.43 29.30 29.65 29.46 29.99
Pivot Point 28.95 28.95 29.06 28.96 28.95
Support 1 (S1) 28.52 28.60 28.73 28.54 28.01
Support 2 (S2) 28.03 28.38 28.05 27.93
Support 3 (S3) 27.60 28.03 27.86
Support 4 (S4) 27.63